CB-7646, a stable analogue of trimelamol (TM), is an anti-tumour agent. Present study shows the effective activity of CB 7646 against various forms of platinum resistance in in vitro models. Curative activity for CB 7646 is seen in the HX110P human ovarian cancer xenograft with acquired carboplatin resistance. References: Coley HM. N-(Hydroxymethyl) melamines. Gen Pharmacol. 1997 Feb;28(2):177-82. Review. PubMed PMID: 9013191.

纯度：≥98%

CAS：104880-54-8